Larvol Delta - A-Trial-to-Assess-the-Longterm-Safety-of-Octreotide-Subcutaneous-Depot-in-Patients-With-Acromegaly

octreotide chloride FluidCrystal Injection depot (CAM2029) - Novartis

http://clinicaltrials.gov/ct2/show/NCT04125836

Jun 22, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next